RUCONEST
2100U INJ PSO LQF 1+1X20ML+STR+2AD+INFSA
| Maximum ex-factory price/Ex-factory price ? | 20265,49 CZK |
|---|---|
| Legal basis of maximum ex-factory price/ex-factory price ? | Maximum ex-factory price set by the law. |
Informace o základní úhradě
| Core reimbursement from health insurance ? | 19979,85 CZK |
|---|---|
| Maximum reimbursement from health insurance ? | 24304,55 CZK |
| Legal basis of reimbursement from health insurance ? | Reimbursement set by the law. |
| Indication restriction of reimbursement ? | Přípravek je hrazen k substituční léčbě akutních atak hereditárního angioedému se závažnými záchvaty v oblasti abdominální, laryngeální nebo v oblasti obličeje u pacientů s deficitem inhibitoru C1-esterázy. U pacientů, kteří tímto přípravkem ještě nebyli léčeni, se před zahájením léčby provedou testy na přítomnost IgE protilátek proti králičímu epitelu (srst). |
| Prescribing doctor's specialisation ? | – |
| Reporting limit ? | S: If it is advisable to concentrate the use of a product in specialist facilities under Section 15(10) of the Act in the public interest, the decision shall allocate the "S" symbol to these products. These products may be charged to the health insurer as a separately charged product solely by specialist facilities under an agreement concluded with the health insurer. |
| Rough price for the final consumer ? | 23681,68 CZK |
| Rough payment for the final consumer (for 1 prescribed package dispensed) ? | 0 CZK |
| Eligible extra payment ? | – |
| Eligible extra payment for individuals aged 65 and older ? | – |
cz